-
Mashup Score: 0Wolters Kluwer Health - 12 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
In an interview with Targeted Oncology for Esophageal Cancer Awareness Month, Arturo Loaiza-Bonilla, MD, MSEd, discussed the pressing need to keep up with the developments in targeted therapies for esophageal and GEJ cancers.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Exploring the current gastroesophageal cancer treatment landscape and near-future developments | COR2ED - 1 year(s) ago
You are invited to join your peers in an interactive online event on current and future treatments for gastroesophageal cancer. Register below.
Source: COR2EDCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 1Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The THUNDER case-control study elicited a 69.1% rate of sensitivity and 98.9% rate of specificity with the OverC™ MCDBT in adult patients with various cancers.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Final Analysis of Diagnostic Endoscopic Resection Followed by Selective Chemoradiotherapy for Stage I Esophageal Cancer: JCOG0508 - 1 year(s) ago
Esophageal cancer is the sixth leading cause of cancer mortality worldwide, and survival is dismal.1 The 5-year overall survival (OS) proportion ranged from 10% to 30% in most countries.2 Thus, improving its prognosis is an urgent issue to be addressed. Globally, 85% of esophageal cancer was squamous cell carcinoma (ESCC).3 Advances in endoscopic diagnostic technology have increased the detection…
Source: GastroenterologyCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0The Cancer News Daily - 1 year(s) ago
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet
New #podcast episode out now! Brian Henick, MD, @ColumbiaMed is involved in a wide range of studies. He recently discussed new therapy approaches for #esophageal cancer, in particular molecular mechanisms and immunotherapies: https://t.co/dk1VLVSXQl https://t.co/GNkfxJa9Zc